|
시장보고서
상품코드
1958892
약물 용출 풍선 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Drug Eluting Balloon Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
약물 용출 풍선 시장 규모는 2025년 18억 3,000만 달러에서 2034년에는 43억 3,000만 달러에 이를 것으로 예측되며, 2026-2034년 CAGR 10.03%를 나타낼 전망입니다.
세계 약물용출형 풍선(DEB) 시장은 심혈관 질환의 유병률 증가와 저침습적 치료법에 대한 수요 증가를 배경으로 큰 폭의 성장이 예상되고 있습니다. 약물용출풍선은 혈관성형술에서 치료제를 동맥경화성 병변 부위에 직접 전달하여 재협착 위험을 감소시키는 특수 의료기기입니다. 의료진들이 혈관 질환 치료에 효과적인 솔루션을 찾고 있는 가운데, 약물 용출 풍선의 채택이 크게 증가하여 이 시장의 기술 혁신과 투자를 촉진할 것으로 예측됩니다.
또한, DEB 기술과 약물 배합의 발전은 약물 용출 풍선 시장을 더욱 촉진할 것으로 예측됩니다. DEB의 유효성과 안전성을 높이는 새로운 약제 조합과 풍선 디자인의 개발로 임상 현장에서의 성능이 향상되고 있습니다. 또한, 환자의 치료 결과와 의료의 질에 대한 관심이 높아지면서 더 나은 장기적 결과를 제공하는 첨단 DEB 솔루션에 대한 수요가 증가하고 있습니다. 제조업체들이 치료 목표 달성에 있어 고품질 약물 용출형 풍선의 중요성을 점점 더 많이 인식함에 따라, 다양한 환자 니즈를 충족시키는 혁신적인 솔루션에 대한 수요가 급증할 것으로 보입니다.
또한, 규제 준수와 임상적 증거에 대한 관심이 높아지면서 약물 용출 풍선 시장 전망를 형성할 것으로 예측됩니다. 규제 당국이 의료기기에 대한 보다 엄격한 가이드라인을 시행하고 확실한 임상 데이터를 요구함에 따라, 이러한 기준을 충족하는 DEB에 대한 수요는 계속 증가할 것입니다. DEB 제조업체, 의료 제공업체 및 규제 당국 간의 협력적 노력은 이러한 발전을 촉진하고 약물 용출 풍선 시장이 심혈관 치료 혁신의 최전선에서 계속 유지될 수 있도록 하는 데 필수적일 것입니다.
목차
제1장 서론
제2장 주요 요약
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 약물 용출 풍선 시장 : 제품 유형별
제5장 세계의 약물 용출 풍선 시장 : 용도별
제6장 세계의 약물 용출 풍선 시장 : 최종사용자별
제7장 세계의 약물 용출 풍선 시장 : 지역별
제8장 경쟁 구도
제9장 기업 개요
LSH 26.03.13The Drug Eluting Balloon Market size is expected to reach USD 4.33 Billion in 2034 from USD 1.83 Billion (2025) growing at a CAGR of 10.03% during 2026-2034.
The global drug eluting balloon (DEB) market is set to experience substantial growth, driven by the increasing prevalence of cardiovascular diseases and the rising demand for minimally invasive treatment options. Drug eluting balloons are specialized medical devices used in angioplasty procedures to deliver therapeutic agents directly to the site of atherosclerotic lesions, reducing the risk of restenosis. As healthcare providers seek effective solutions for treating vascular diseases, the adoption of drug eluting balloons is expected to rise significantly, fostering innovation and investment in this market.
Moreover, advancements in DEB technology and drug formulations are anticipated to further boost the drug eluting balloon market. The development of new drug combinations and balloon designs that enhance the efficacy and safety of DEBs is improving their performance in clinical settings. Additionally, the growing emphasis on patient outcomes and quality of care is driving the demand for advanced DEB solutions that provide better long-term results. As manufacturers increasingly recognize the importance of high-quality drug eluting balloons in achieving therapeutic goals, the market is likely to witness a surge in demand for innovative solutions that cater to diverse patient needs.
In addition, the increasing focus on regulatory compliance and clinical evidence is expected to shape the future of the drug eluting balloon market. As regulatory bodies implement stricter guidelines for medical devices and require robust clinical data, the demand for DEBs that meet these standards will continue to rise. Collaborative efforts between DEB manufacturers, healthcare providers, and regulatory agencies will be essential in driving these advancements, ensuring that the drug eluting balloon market remains at the forefront of cardiovascular treatment innovation.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Product Type
- Peripheral Drug Eluting Balloons
- Coronary Drug Eluting Balloons
- Others
By Application
- Peripheral Artery Disease
- Coronary Artery Disease
- Others
By End-User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
COMPANIES PROFILED
- Medtronic, Boston Scientific Corporation, B Braun Melsungen AG, Cook Medical, Biotronik, Abbott Laboratories, Terumo Corporation, Surmodics Inc, Eurocor GmbH, Meril Life Sciences Pvt Ltd, Concept Medical Inc, MedAlliance SA, Biosensors International Group Ltd, Cardionovum GmbH, Acotec Scientific Co Ltd
We can customise the report as per your requriements
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL DRUG ELUTING BALLOON MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Product Type
- 4.2. Peripheral Drug Eluting Balloons Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Coronary Drug Eluting Balloons Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL DRUG ELUTING BALLOON MARKET: BY APPLICATION 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Application
- 5.2. Peripheral Artery Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Coronary Artery Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL DRUG ELUTING BALLOON MARKET: BY END-USER 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast End-user
- 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL DRUG ELUTING BALLOON MARKET: BY REGION 2022-2034(USD MN)
- 7.1. Regional Outlook
- 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Product Type
- 7.2.2 By Application
- 7.2.3 By End-user
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
- 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Product Type
- 7.3.2 By Application
- 7.3.3 By End-user
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
- 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Product Type
- 7.4.2 By Application
- 7.4.3 By End-user
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
- 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Product Type
- 7.5.2 By Application
- 7.5.3 By End-user
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 South East Asia
- 7.5.9 Rest of Latin America
- 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Product Type
- 7.6.2 By Application
- 7.6.3 By End-user
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa
Chapter 8. COMPETITIVE LANDSCAPE
- 8.1. Recent Developments
- 8.2. Company Categorization
- 8.3. Supply Chain & Channel Partners (based on availability)
- 8.4. Market Share & Positioning Analysis (based on availability)
- 8.5. Vendor Landscape (based on availability)
- 8.6. Strategy Mapping
Chapter 9. COMPANY PROFILES OF GLOBAL DRUG ELUTING BALLOON INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Company Profiles
- 9.2.1 Medtronic
- 9.2.2 Boston Scientific Corporation
- 9.2.3 B. Braun Melsungen AG
- 9.2.4 Cook Medical
- 9.2.5 Biotronik
- 9.2.6 Abbott Laboratories
- 9.2.7 Terumo Corporation
- 9.2.8 Surmodics Inc
- 9.2.9 Eurocor GmbH
- 9.2.10 Meril Life Sciences Pvt. Ltd
- 9.2.11 Concept Medical Inc
- 9.2.12 MedAlliance SA
- 9.2.13 Biosensors International Group Ltd
- 9.2.14 Cardionovum GmbH
- 9.2.15 Acotec Scientific Co. Ltd
